Ebola vaccine licensure is underway
With the help of two University of Florida researchers, an Ebola vaccine is closer to being licensed.
Once the vaccine is licensed, it will be more accessible to those who are most at risk to contract the virus.
UF collaborated with the World Health Organization to test the Ebola vaccine.
According to the study's findings, the vaccine was nearly 100% effective at preventing the virus when given 10 or more days before exposure.
“It has had a large impact on protecting a lot of people,” said Natalie Dean, UF assistant professor of biostatistics. “Ebola is a very severe disease with very high fatality rates so to be able to see something that we worked on actually protect and save lives, of course, that’s very gratifying.”
Dean along with other UF researchers hope to create other vaccines for the Zika virus and Middle East Respiratory Syndrome (MERS).
“It was really exciting to be a part of this trial,” Dean said. “Obviously, people have been working for a long time on this vaccine before but there were a lot of challenges in figuring it out on how to evaluate whether the vaccine worked."